[5-hydroxy-3-methyl-5-(trifluoromethyl)-4H-pyrazol-1-yl]-(4-iodo-1-methylpyrazol-3-yl)methanone
C10H10F3IN4O2 — CID 5106945
Data last refreshed: (MolForge compound catalog, from PubChem)
About [5-hydroxy-3-methyl-5-(trifluoromethyl)-4H-pyrazol-1-yl]-(4-iodo-1-methylpyrazol-3-yl)methanone
[5-hydroxy-3-methyl-5-(trifluoromethyl)-4H-pyrazol-1-yl]-(4-iodo-1-methylpyrazol-3-yl)methanone (PubChem CID 5106945) has the molecular formula C10H10F3IN4O2 and a molecular weight of 402.11 g/mol. Its IUPAC name is [5-hydroxy-3-methyl-5-(trifluoromethyl)-4H-pyrazol-1-yl]-(4-iodo-1-methylpyrazol-3-yl)methanone.
Molecular Properties
| Compound Name | [5-hydroxy-3-methyl-5-(trifluoromethyl)-4H-pyrazol-1-yl]-(4-iodo-1-methylpyrazol-3-yl)methanone |
|---|---|
| PubChem CID | 5106945 |
| Molecular Formula | C10H10F3IN4O2 |
| Molecular Weight | 402.11 g/mol |
| Exact Mass | 401.98 |
| IUPAC Name | [5-hydroxy-3-methyl-5-(trifluoromethyl)-4H-pyrazol-1-yl]-(4-iodo-1-methylpyrazol-3-yl)methanone |
| SMILES | CC1=NN(C(=O)c2nn(C)cc2I)C(O)(C(F)(F)F)C1 |
| InChI | InChI=1S/C10H10F3IN4O2/c1-5-3-9(20,10(11,12)13)18(15-5)8(19)7-6(14)4-17(2)16-7/h4,20H,3H2,1-2H3 |
| InChIKey | WTHOSPYNAYYAIJ-UHFFFAOYSA-N |
| XLogP | 1.50 |
| TPSA | 70.72 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 1 |
| Heavy Atoms | 20 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 402.11 |
| LogP ≤ 5 | 1.50 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'iodine', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 5106945 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.